【作者】 廖贵清； 黄洪章； 张志光； 曾融生； 杨小平； 郑有华； 何一青； 陈卓辉；

【Author】 Liao Guiqing Huang Hongzhang Zhang Zhiguang Zeng Rongsheng Yang Xiaoping Zheng Youhua He Yiqing Cheng Zhuohui Department of oral and maxillofacial Surgery, Scholl of stomatology, Sun Yat-Sen University of medical Sciences, Guanzhou, China 510060

【机构】 中山医科大学口腔医学院；

【摘要】 <正>目的:探讨口腔颌面部恶性肿瘤近期复发的原因及外科处理方法。材料和方法:选择近5年完整住院病历的口腔颌面部恶性肿瘤200例,全部病例均手术治疗。对其进行一年的随访观察并对复发病例进行外科手术为主的综合治疗。总结复发病例,从原发灶部位、生长方式及病理类型更多还原

【Abstract】 Objective: To analysis the reason of short-term recurrence of the malignant tumor in oral and maxillofacial regions and to investigate their surgical management. Material and methods: 200 cases with malignant tumor of oral and maxillofacial regions, treated mainly by surgery, were selected for one-year’s follow-up study. The relationship between recurrence and the site, size, infiltrating manner, pathological feature of the primary lesion was analyzed carefully. Surgical management was applied to deal with the recurrent patients. Results:(1)The short-term recurrent rate of oral and maxilllofacial malignant tumor was 20.5%(41/200), and the controlled period from radical operation to the diagnosis if recurrence was 2 weeks～12 months (the mean time 4.5 month); (2)The recurrent of lingual, buccal and oroparngeal carinoma was higher than that of palate gingival, floor of mouth and facial skin. Besides, malignant melanoma, Ewing’s sarcoma, rahdosarcoma, central carcinoma of jaws and malignant schwannoma had a relatively high recurrent rate. (3)The infiltrating manner of tumor was closely related to their possibility of recurrence, but the selection of preoperative chemotherapy, radiotherapy was not deal with the short-term postoperative recurrence. Conclusion: The recurrent rate of oral and maxillofacial malignant tumor was pretty high, and related to side, size, pathological feature and infiltrating manner, but was not related to the selection of preoperative chemotherapy and radiotherapy. Surgical management was the main methods to deal with the recurrent cases, but the no-tumor process should be emphasized for any tumor surgeons.更多还原